Lisanti Capital Growth LLC Purchases New Shares in Hinge Health Inc. $HNGE

Lisanti Capital Growth LLC bought a new position in Hinge Health Inc. (NYSE:HNGE) during the second quarter, HoldingsChannel.com reports. The fund bought 59,700 shares of the company’s stock, valued at approximately $3,089,000.

Other institutional investors have also recently made changes to their positions in the company. Emerald Advisers LLC bought a new stake in Hinge Health during the second quarter worth approximately $108,000. Mark Sheptoff Financial Planning LLC bought a new position in shares of Hinge Health during the 2nd quarter valued at approximately $114,000. FNY Investment Advisers LLC bought a new position in shares of Hinge Health during the 2nd quarter valued at approximately $310,000. Strategic Blueprint LLC purchased a new stake in Hinge Health during the 2nd quarter valued at $346,000. Finally, CHURCHILL MANAGEMENT Corp bought a new stake in Hinge Health in the second quarter worth $828,000.

Analyst Ratings Changes

A number of research firms have weighed in on HNGE. Citizens Jmp assumed coverage on shares of Hinge Health in a research note on Monday, July 14th. They issued a “strong-buy” rating and a $58.00 target price on the stock. Citigroup began coverage on Hinge Health in a research report on Monday, July 14th. They set an “outperform” rating for the company. Wall Street Zen raised shares of Hinge Health from a “hold” rating to a “buy” rating in a research note on Saturday. Weiss Ratings reissued a “sell (d)” rating on shares of Hinge Health in a research note on Wednesday, October 8th. Finally, KeyCorp increased their price target on Hinge Health from $45.00 to $60.00 and gave the stock an “overweight” rating in a research report on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $59.93.

Hinge Health Stock Up 0.9%

HNGE stock opened at $44.43 on Friday. The firm’s 50-day moving average price is $52.43. Hinge Health Inc. has a one year low of $33.42 and a one year high of $62.18.

Hinge Health (NYSE:HNGE) last posted its earnings results on Tuesday, November 4th. The company reported ($0.02) EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.18. The firm had revenue of $154.21 million for the quarter, compared to analysts’ expectations of $142.44 million. Hinge Health’s revenue for the quarter was up 53.3% compared to the same quarter last year. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.